Twist Bioscience to Present at Baird Global Healthcare Conference 2024
Twist Bioscience Corporation (TWST)
Last twist bioscience corporation earnings: 2/6 04:05 pm
Check Earnings Report
Company Research
Source: Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Baird Global Healthcare Conference 2024 in New York City on Tuesday, September 10 at 2:35 p.m. Eastern Time.The presentation will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the presentation will be archived for a period of 30 days following the conclusion of the live events.About Twist Bioscience CorporationTwist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new
Show less
Read more
Impact Snapshot
Event Time:
TWST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TWST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TWST alerts
High impacting Twist Bioscience Corporation news events
Weekly update
A roundup of the hottest topics
TWST
News
- DNA Synthesizer Market Projected to Reach USD 922.11 Million by 2032, Growing at a 14.62% CAGR – SNS Insider [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Full Year 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at Barclays PLC from $55.00 to $52.00. They now have an "overweight" rating on the stock.MarketBeat
- Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Scotiabank from $50.00 to $54.00. They now have a "sector outperform" rating on the stock.MarketBeat
- Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Robert W. Baird from $46.00 to $48.00. They now have an "outperform" rating on the stock.MarketBeat
TWST
Earnings
- 11/18/24 - Beat
TWST
Sec Filings
- 11/18/24 - Form S-8
- 11/18/24 - Form 10-K
- 11/18/24 - Form 8-K
- TWST's page on the SEC website